Brandon Wei
Houston, TXNPI 1902556962
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 161 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 10.9% — the pattern of someone who eats at a lot of different presentations.
Across 161 payments — averaging $23.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$420
- UCB, Inc.$362
- SK Life Science, Inc.$323
- AbbVie$280
- AstraZeneca$273
- CSL Behring$254
- plus $2K from 18 others
What the payments were for
- Food & beverage$3,836100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 19 | $420 |
| UCB, Inc. | 15 | $362 |
| SK Life Science, Inc. | 4 | $323 |
| AbbVie | 14 | $280 |
| AstraZeneca(2 entities) | 14 | $273 |
| CSL Behring | 11 | $254 |
| Acadia Pharmaceuticals Inc | 11 | $252 |
| Genentech USA, Inc. | 12 | $252 |
| Argenx US, Inc. | 10 | $243 |
| Eisai Inc. | 7 | $209 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $142 |
| Sanofi | 6 | $126 |
| Johnson & Johnson(2 entities) | 6 | $120 |
| Amgen(2 entities) | 3 | $117 |
| Biogen | 6 | $114 |
| Springworks Therapeutics, Inc. | 3 | $74 |
| Grifols USA, LLC | 4 | $72 |
| Otsuka America Pharmaceutical, Inc. | 2 | $51 |
| Tanabe Pharma America, Inc. | 3 | $43 |
| EMD Serono, Inc. | 2 | $37 |
| Neurelis, Inc. | 1 | $23 |
| Amicus Therapeutics, Inc. | 1 | $20 |
| Pfizer | 1 | $17 |
| Microtransponder, Inc. | 1 | $14 |
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.